Today: October 24, 2024
February 18, 2022
1 min read

They leave without effect the prohibition that prevented entering the Police Palace without a mask

They leave without effect the prohibition that prevented entering the Police Palace without a mask

The CEO of the National PoliceEduardo Alberto Then, annulled memorandum No. 5282, which prohibited the movement of people in the Palace of the institution without the use of a mask.

With a new memorandum, No. 5466, dated February 16, Alberto Then annuls the previous one, in accordance with the provisions of the President of the Republic, Luis Abinader, who yesterday suspended all the restrictive measures taken by COVID-19.

“The use of any means to keep ourselves protected from diseases in the future will be the responsibility of each and every one of us,” said Major General Alberto Then, following the government line.

The repealed document sought to prevent the access of people without masks to the institutional headquarters to prevent the spread of the respiratory disease.

DR is back to normal

Almost two years after the arrival of the pandemic, President Luis Abinader decided to suspend all the measures imposed by COVID-19, including the use of the mask and the carrying of the vaccination card to enter all places.

Abinader justified his decision by the low incidence of the disease in the country after passing a fifth wave of infections.

With this decision, the Dominican Republic became the first country in Latin America to suspend all its restrictions.

It may interest you

Leading newspaper in the Dominican Republic focused on general news and innovative journalism.

Source link

Latest Posts

They celebrated "Buenos Aires Coffee Day" with a tour of historic bars - Télam
Cum at clita latine. Tation nominavi quo id. An est possit adipiscing, error tation qualisque vel te.

Categories

cromo
Previous Story

Labat: the dollar will be allowed to float and will have a "mild" go up this year

Molnupiravir to treat COVID-19: Digemid authorizes drug marketing
Next Story

Molnupiravir to treat COVID-19: Digemid authorizes drug marketing

Latest from Blog

Go toTop